USO 16041

An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies Investigational Product(s), Dose and Mode of Administration, Duration of Treatment with Investigational

Disease Types

Advanced/Metastatic Malignancies

Available at

BethesdaClintonColumbiaRockvilleSilver SpringWheaton

Contact

Cheryl A. Young, RN, BSN
(410) 964-2212 ext 1137